일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
2019/03/29 | 21:25 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2019/03/29 | 19:09 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2019/03/28 | 04:04 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2019/03/27 | 21:30 | GlobeNewswire Inc. | Pain Therapeutics Announces Name Change to Cassava Sciences, Inc. | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2019/03/26 | 02:10 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2019/03/25 | 21:30 | GlobeNewswire Inc. | Pain Therapeutics Reports 2018 Financial Results and Corporate Update | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2019/03/23 | 05:10 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2019/03/05 | 04:56 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2019/02/15 | 05:04 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2019/02/15 | 03:47 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2019/02/14 | 06:36 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2019/02/12 | 06:48 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2019/02/09 | 06:06 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2019/02/09 | 03:11 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2019/02/08 | 07:13 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2019/02/06 | 03:09 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2019/02/05 | 22:00 | GlobeNewswire Inc. | Pain Therapeutics Announces Feedback from Recent Meeting with FDA on REMOXY | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2019/01/31 | 20:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2019/01/17 | 23:00 | GlobeNewswire Inc. | Pain Therapeutics Announces Academic Collaboration with The University of Texas at Austin | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2019/01/16 | 23:00 | GlobeNewswire Inc. | Pain Therapeutics Awarded $1.5 Million Research Grant by National Institutes of Health | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2019/01/07 | 22:30 | GlobeNewswire Inc. | Pain Therapeutics Announces Two New Peer-Reviewed Publications for REMOXY | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2018/12/19 | 08:00 | GlobeNewswire Inc. | Pain Therapeutics Announces Filing of Registration Statement on SEC Form S-1 | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2018/12/19 | 07:29 | Edgar (US Regulatory) | Securities Registration Statement (s-1) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2018/12/11 | 05:46 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2018/12/06 | 21:30 | GlobeNewswire Inc. | Pain Therapeutics Announces Initiation of a Phase II Study in Alzheimer’s Disease | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2018/11/12 | 21:30 | GlobeNewswire Inc. | Pain Therapeutics Appeals FDA Decision on REMOXY | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2018/11/02 | 05:34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2018/11/01 | 05:04 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2018/10/31 | 05:44 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
2018/10/30 | 05:09 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |